ZZPZH(600436) 证券时报网·2024-11-16 03:40Core Viewpoint - Guangshentang (300436) has successfully introduced a strategic investor, Zhangzhou Yuanshan Health Industry Investment Fund, which is affiliated with another well-known pharmaceutical company, Pianzihuang (600436) [1] Group 1: Share Transfer Details - Fujian Aohua Group, the controlling shareholder of Guangshentang, will transfer 800,000 shares (5.02% of total shares) to Yuanshan Fund at a price of 24.5 yuan per share, totaling 196 million yuan [2] - The share transfer price is set at 80% of the closing price on the trading day prior to the agreement [2] - Following this transfer, the shareholding of Aohua Group and its concerted parties will decrease from 49.41% to 40.89% [1][2] Group 2: Background of Yuanshan Fund - Yuanshan Fund was established on July 12, 2024, with contributions from various partners, including Pianzihuang Asset Management and Zhangzhou Investment [2][3] - Pianzihuang Asset Management holds a 30% stake, while Pianzihuang Investment holds 40% [2] - The fund aims to leverage professional investment resources to enhance the integration capabilities within the pharmaceutical industry [3] Group 3: Strategic Intentions - The introduction of Yuanshan Fund is intended to optimize Guangshentang's shareholder structure and attract long-term investors [4] - Both companies aim to enhance industrial collaboration and resource sharing, thereby strengthening their competitive edge in the pharmaceutical sector [3][4] - Guangshentang focuses on developing a range of liver health products and is expanding into cardiovascular and male health sectors [3]